Search results
Results from the WOW.Com Content Network
Gastroesophageal reflux disease (GERD) or gastro-oesophageal reflux disease (GORD) is a chronic upper gastrointestinal disease in which stomach content persistently and regularly flows up into the esophagus, resulting in symptoms and/or complications.
Tharizdun has been depicted on the cover of Gygax's Gord the Rogue novel Come Endless Darkness as a huge, bald, humanoid man, with claws, greenish-black skin, and pointed ears. Gygax said that in the Gord novels, "the worst and most terrible of Tharizdun's forms could come into full power and attack". [27]
Ilaprazole (trade name Noltec) is a proton pump inhibitor (PPI) used in the treatment of dyspepsia, peptic ulcer disease (PUD), gastroesophageal reflux disease (GORD/GERD) [1] and duodenal ulcer. [2] [3] It is available in strengths of 5, 10, and 20 mg.
Lansoprazole is used for treatment of: [3] Ulcers of the stomach and duodenum, and NSAID-induced ulcers; Helicobacter pylori infection, alongside antibiotics (adjunctive treatment), treatment to kill H. pylori causing ulcers or other problems involves using two other drugs besides lansoprazole known as "triple therapy", and involves taking twice daily for 10 or 14 days lansoprazole ...
The cost of Slopeside Syrup's employee health insurance premiums spiked 24% this year. The jumps mean less money to pay workers, and expensive insurance coverage that doesn't ensure employees can ...
Near the gord, or below it in elevation, there formed small communities of servants, merchants, artisans, and others who served the higher-ranked inhabitants of the gord. Each such community was known as a suburbium (literally "undercity") (Polish: podgrodzie). Its residents could shelter within the walls of the gord in the event of danger.
The FDIC is an independent government agency charged with maintaining stability and public confidence in the U.S. financial system and providing insurance on consumer deposit accounts.
In patients with duodenal ulcers, troxipide showed endoscopic healing rate of 53.3% and 73% at 8 weeks and 12 weeks respectively. At the end of the treatment, an overall improvement of 86.6% and 93.3% was achieved in patients with gastric ulcer and duodenal ulcer respectively. [ 23 ]